Vergency combines technologies from different industries to create new opportunities in the consumer health market. It specializes in liberating technologies stranded in large corporations and combining them into profitable products. Vergency's team has experience in innovation, entrepreneurship, and healthcare. It will generate value for investors by engineering the convergence of assets from corporate partners into commercialized companies, which will then be exited through acquisition, IPO, or sale.

2. Evolutionary, Revolutionary and Disruptive:
New Opportunities In Mass-Market Health

3. Vergency combines technologies from different
industries to seize opportunities in the new
consumer-focused health care market
• Health is rapidly transforming into an industry focused on individual
consumers!
• The technologies that could serve the new health consumers are often
stranded in large corporations!
• Vergency specializes in liberating these stranded health technolgies and
combining them into profitable new mass-market offers!

4. Health is rapidly transforming into an industry
focused on individual consumers!
• Health care traditionally has cured diseases through large institutions – think
hospitals and pharaceutical companies – with deep technocratic expertise!
• Things are changing now, as aging populations are overwhelming traditional
health care systems and consumers increasingly expect new technologies to
give them individual, proactive control of their health!
• So the next few years will see highly profitable opportunities in health
products that respond to this emerging tidal wave of consumer demand!

5. Health care traditionally has cured diseases through large institutions – think
hospitals and pharaceutical companies – with deep technocratic expertise!
TRADITIONAL HEALTH CARE INDUSTRIAL MODEL
Large
institution
Centralized
engineering
Delivery via
standardizd protocols
+ =

6. Things are changing now, as aging populations are overwhelming traditional
health care systems and consumers increasingly expect new technologies to
give them individual, proactive control of their health!
NEW CONSUMER-DRIVEN HEALTH MARKET
Individual consumer
Centralized
engineering
Dynamic marketplace
+ =Variety of choices

7. So the next few years will see highly profitable opportunities in health products
that respond to this emerging tidal wave of consumer demand!
NEXT OPPORTUNITIES IN HEALTH CARE
APPS! NEUTRACEUTICALS! HEALTH TOURISM! MOOD FOOD!
PILLS WITH DATA! SMART SPACES! DYNAMIC INSURANCE! WELLNESS TREATMENTS!
HOME DIAGNOSTICS! REMOTE FAMILY DOCTOR! HEALTH COACHES!
SELF-MANAGED !
HEALTH DATA!
PERSONALIZED MEDICINE!
HOME MEDICAL
EQUIPMENT!
PILL-ON-DEMAND! DIAGNOSTIC WEARABLES!

8. The technologies that could serve the new health
consumers are often stranded in large corporations!
• Many large corporations have created innovative technology offerings that
could be highly profitable in the new consumer health market!
• But while they are good at creating innovative technologies, these same
corporations are bad at getting them profitably to market!
• Stranded by regulations and conventional thinking, these technologies need
bespoke networks to connect to the right business models and distribution!

9. Many large corporations have created innovative technology offerings that could
be highly profitable in the new consumer health market!
Hi
Lo
Volume of innovation efforts
Last 10 years
Core
process
Process
Enabling
process
Business
model
Finance
Networking Product
performance
Offering
Product
system
Service Channel
Delivery
Brand Customer
experience
Source: Doblin, Chigaco
Corporate innovation efforts are typically focused on their product offering …

10. But while they are good at creating innovative technologies, these same
corporations are bad at getting them profitably to market!
… while most of the the value is created on finance and customer delivery sides …
Hi
Lo
Core
process
Process.
Enabling
process
Business
model
Finance
Networking Product
performance
Offering
Product
system
Service Channel
Delivery
Brand Customer
experience
Vergency areas of focus
Cumulative value creation – last 10 years: Less than 2% of projects produced
90% of the value…

11. Stranded by regulations and conventional thinking, these technologies need
bespoke networks to connect to the right business models and distribution!
… therefore Vergency unlocks the value of stranded assets
by combining the missing elements through networks …
Technologies stranded!
in corporate silos …!
… need a common vision !
and a strong network …!
… to be convened with missing !
elements into value-creating companies!

12. Vergency specializes in liberating stranded health
technologies and combining them into profitable new
mass-market offers!
• The Vergency team has extensive entreprenerial experience in fund
management, technology transfer, and health care innovation.!
• Vergency creates new commercial opportunities by doing what individual
companies cannot – engineering a space where technologies can be
combined into new products!
• Whether the new companies are sold back to their originators or others – or
spun out in an IPO – Vergency will generate substantial return for investors!

13. Investment Scenario 1: Bottom-of-pyramid opportunity to create scalable
network-based business that directly and profitably improves family health in
developing nations!
[HYPOTHETICAL]!
INVESTEE 1a: Farming
family services!
Multi-billion-$,100+ year-old !
manufacturer of grain-processing!
technologies in 120 countries!
Value: CSR gains by offering grain-
growing families alternative to payment
in de-husked grain currently driving
child malnutrition; competitive
advantage vs. traditional mills!
Deal format: Exclusive supplier of
advanced payment system – bolt-on to
existing mills!
INVESTEE 1b: Payments!
Advanced, muli-modal corporate
payments system; existing tech +
team; ready for rapid growth!
Value: Enables many formats of
payment, including insurance
premiums and reimbursement!
Deal format: Equity investment or!
long-term territory licencee!
!
INVESTEE 1c: Kiosk
Village kiosk network for data-
supported delivery of water and other
critical health products; regional trial
currently turning over $1M/year; ready
for rapid growth!
Value: Creates access to delivery in
villages where individual residences do
not have addresses!
Deal format: Equity investment!
!
INVESTEE 1d: Power!
Village-based freestanding solar
energy company prioviding battery
power to families!
Value: Leaps capital-intesive energy
networks to anchor free-standing
businesses in each village!
Deal format: Equity investment!
!
!
!
Developing nations health ecosytem:
Sophisticated payment and home-delivery
networks give BOP families access to
critical health inputs: water, nutrition-
dense food, electricity, micro-insurance,
etc.

14. Investment Scenario 2: Integrated digital health information infrastructure and
services ecosystem supports new ways of fostering the health of individuals
through carefully curated…!
[HYPOTHETICAL]!
INVESTEE 1a!
xx!
Value: xxx!
Deal format: xxx!
INVESTEE 1b: Adherence!
xx!
Value: xxx!
Deal format: xxx!
!
INVESTEE 1c
xx!
Value: xxx!
Deal format: xxx!
!
INVESTEE 1d: Wearables
data AI!
xx!
Value: xxx!
Deal format: xxx!
!
!
!
Digital health ecosytem: xxx

15. The Vergency team has extensive entreprenerial experience in fund
management, technology transfer, and health care innovation.!
Wolfgang Renz (MD,
PhD) was President of
International Business at
Physicians Interactive.
Formerly, he served as
Corporate Vice President
of Business Model &
HealthCare Innovation at
Boehringer Ingelheim. At
Boehringer, he led a team
of specialists to find, test,
and develop the
disruptive technologies
that will shape the way
health care will be
delivered in the future. He
is Adjunct Professor of
Surgery at McGill
University’s Faculty of
Medicine and holds a
medical degree and a
PhD from Freiburg
University.
Jens Maier (PhD, MBA,
MEng) is a consultant,
entrepreneur, and
business school teacher
(University of St. Gallen
and London Business
School). At Daimler Benz
Aerospace he was Head
of Management
Development and Vice
President Governmental
Affairs, and at Zurich
Financial Services he
served as Head of
Capability Development.
He holds a PhD
(Warwick), an MBA
(Bradford) and an MEng
(Hamburg). He is the
author of “The
Ambidextrous
Organization – exploring
the new while exploiting
the now.”!
Trained at McKinsey &
Company, John Knechtel
is a serial innovator,
consultant, and
entrepreneur. Most
recently – as Co-Founder
& Chief
Operating Officer at
Sparkup Inc. – an online
marketplace for IP –
John helped build
the company’s product
and engineered the
firm’s acquisition by the
UK’s Big Innovation
Centre. Previously, John
created the
multidisciplinary think-
tank Alphabet City,
which produced a
anthology series – paired
with an annual ideas
festival – with The MIT
Press
Toni Rinow (Ph.D.,
MBA, Eng.) is a leader
in company and fund
management. Toni’s
brainpower in science &
engineering is the
source of her early
understanding of new
technologies, creative
imagining of new ideas,
and assessment of their
future viability. She has
overseen large
portfolios (at Fonds
FTQ with $400M+ in life
science and venture
funds). Her experience
includes $100M+ in
licensing, R&D transfer,
and research
commercialization. Her
financial transaction
expertise includes IPOs,
banks, crown
corporations, venture
capital.
Bill Smith is the
Founder and CEO of
Brand Acumen and
Chairman and
managing Director at
Harrison Hayes, a Life
Science Venture
Capital Firm. Bill is
responsible for naming
products which have
generated over $1
Trillion in revenue for
his clients. He has
penned such iconic
brand names as
Escalade (Cadillac),
XBox (Microsoft),,
Avastin (Roche), and
Element (Honda).
Harrison Hayes
manages a family of
Venture Funds
including BioArbitrage
Funds I, II and III and
The Orphanetics Rare
Disease Innovation
Fund.!

16. Vergency creates new commercial opportunities by doing what individual
companies cannot – engineering a space where stranded technologies can be
combined into new products!
VERGENCY’S CONVERGENCE ENGINE
Network: !
Vergency team has
the relationships
required to access
opportunties across
relevant industries!
!
• Currently produce
convergence seminar series
for corporate leaders!
!
• Team members publishing
convergence book series!
!
• Brand Acumen/Harrison
Hayes clientele!
!
• Linklaters round tables on
sustainable innovation in
health care!
!
• & cetera!
!
Catalyst: !
C-suite relationships
that will drive action
by corporate partners
to move projects into
Vergency!
• Building an agenda for
growth through convergence!
!
• Identify convergence assets!
!
• Generate new convergence
opportunities!
Asset:!
Technology projects
stranded inside
innovation units of
corporate partners!
• !
Accelerator:!
Convergence project
that combines
technology assets
and drives
commercialization!
!
• Create a strong hypothesis
on value-creating combination!
!
• Add missing elements!
!
• Engineer new converged
product!
!
• Take to market and grow!
!
• Exit!

17. Whether the new companies are sold back to their originators, acquired, or spun
out in an IPO – Vergency will generate substantial returns for investors!
VERGENCY FUND SPECIFICATIONS
Target ROI: 20 to 25% (6 x LP investment)
Fund size: $250M
Maximum investor commitment: $50M
Exits: within 5 to 7 years through acquisition, IPO, or sale back to originating corporation
Size of investments: $5M - $10M
Invstment characteristics: Later-phase projects with mature technologies
Management fees: 2.5 %
GP carried interest: 20 %